We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

30 hedge funds and large institutions have $1.58M invested in Perspective Therapeutics in 2018 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% less ownership

Funds ownership: 0.72% → 0.63% (-0.08%)

5% less capital invested

Capital invested by funds: $1.66M → $1.58M (-$81K)

3% less funds holding

Funds holding: 31 → 30 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
30
Holders Change
-1
Holders Change %
-3.23%
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
+$14.9K
2
Invesco
Invesco
Georgia
+$7.52K
3
BlackRock
BlackRock
New York
+$1.16K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$137K
2
Citadel Advisors
Citadel Advisors
Florida
-$57K
3
UBS Group
UBS Group
Switzerland
-$9.31K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$7.37K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$7.01K

CATX Hedge Fund Activity: Q2 2018 in Review

30 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q2 2018, worth a combined $1.58M — down 4.9% from $1.66M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of CATX and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was Virtu Financial, opening a new position worth an estimated $14.9K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $137K sold.

  • 30 institutional investors held Perspective Therapeutics (CATX) as of Q2 2018, down from 31 in Q1 2018.
  • Funds reported $1.58M of Perspective Therapeutics stock for Q2 2018, down 4.9% quarter-over-quarter.
  • 2 funds opened new Perspective Therapeutics positions in Q2 2018 and 3 closed out, a net change of -1 holder.
  • The largest Perspective Therapeutics buyer in Q2 2018 was Virtu Financial, an estimated $14.9K added.
  • The largest Perspective Therapeutics seller in Q2 2018 was Susquehanna International Group, an estimated $137K sold.

Based on aggregated 13F filings for Q2 2018.